MA35283B1 - Produits de recombinaison destinés à inactiver le gène p0 et leur utilisation - Google Patents

Produits de recombinaison destinés à inactiver le gène p0 et leur utilisation

Info

Publication number
MA35283B1
MA35283B1 MA36709A MA36709A MA35283B1 MA 35283 B1 MA35283 B1 MA 35283B1 MA 36709 A MA36709 A MA 36709A MA 36709 A MA36709 A MA 36709A MA 35283 B1 MA35283 B1 MA 35283B1
Authority
MA
Morocco
Prior art keywords
inactivating
gene
recombinant products
sequence
recombinant
Prior art date
Application number
MA36709A
Other languages
English (en)
Inventor
Elodie Klein
Véronique Graff
David Gilmer
Véronique Brault
Guy Weyens
Marc Lefebvre
Original Assignee
SESVanderHave NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44907563&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA35283(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by SESVanderHave NV filed Critical SESVanderHave NV
Publication of MA35283B1 publication Critical patent/MA35283B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Physiology (AREA)
  • Botany (AREA)
  • Developmental Biology & Embryology (AREA)
  • Environmental Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Cette invention concerne une séquence de nucléotides du virus bmyv p0 qui, une fois transcrite dans une cellule, est capable de former une séquence arn double brin auto-complémentaire.
MA36709A 2011-06-23 2014-01-22 Produits de recombinaison destinés à inactiver le gène p0 et leur utilisation MA35283B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11171196A EP2537936A1 (fr) 2011-06-23 2011-06-23 Constructions de silençage du gène P0 et leur utilisation
PCT/EP2012/061436 WO2012175420A1 (fr) 2011-06-23 2012-06-15 Produits de recombinaison destinés à inactiver le gène p0 et leur utilisation

Publications (1)

Publication Number Publication Date
MA35283B1 true MA35283B1 (fr) 2014-07-03

Family

ID=44907563

Family Applications (1)

Application Number Title Priority Date Filing Date
MA36709A MA35283B1 (fr) 2011-06-23 2014-01-22 Produits de recombinaison destinés à inactiver le gène p0 et leur utilisation

Country Status (17)

Country Link
US (2) US9932603B2 (fr)
EP (2) EP2537936A1 (fr)
CN (1) CN103635581B (fr)
CA (1) CA2839371A1 (fr)
CL (1) CL2013003466A1 (fr)
DK (1) DK2723873T4 (fr)
EA (1) EA029359B1 (fr)
ES (1) ES2647077T5 (fr)
HU (1) HUE035070T2 (fr)
LT (1) LT2723873T (fr)
MA (1) MA35283B1 (fr)
PL (1) PL2723873T5 (fr)
PT (1) PT2723873T (fr)
SI (1) SI2723873T1 (fr)
TN (1) TN2013000498A1 (fr)
UA (1) UA114603C2 (fr)
WO (1) WO2012175420A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150291969A1 (en) * 2014-01-30 2015-10-15 Chromatin, Inc. Compositions for reduced lignin content in sorghum and improving cell wall digestibility, and methods of making the same
CN110938645A (zh) * 2019-12-17 2020-03-31 中国农业大学 一种甘蔗黄叶病毒运动蛋白表达纯化方法及其多克隆抗血清的制备
WO2021234101A1 (fr) * 2020-05-20 2021-11-25 KWS SAAT SE & Co. KGaA Résistance à plusieurs virus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0517833T4 (da) 1990-03-02 2008-11-17 Bayer Bioscience Nv Genetisk transformation og regenering af sukkerroer
US7663024B2 (en) * 1998-07-10 2010-02-16 Sesvanderhave, N.V. P15 hairpin constructs and use
EP1029923A1 (fr) 1999-01-27 2000-08-23 D.J. Van Der Have B.V. Procédé conférant aux betteraves sucrières une résistance à une infection par BNYVV
WO2009141446A1 (fr) 2008-05-23 2009-11-26 Syngenta Participations Ag Plantes de betterave sucrière transgéniques
US20120144516A1 (en) 2008-12-19 2012-06-07 Syngenta Participations Ag Transgenic sugar beet event gm rz13

Also Published As

Publication number Publication date
CN103635581A (zh) 2014-03-12
SI2723873T1 (sl) 2017-11-30
US20180265888A1 (en) 2018-09-20
EA201490160A1 (ru) 2014-04-30
EP2723873B2 (fr) 2020-01-15
PL2723873T5 (pl) 2020-07-13
EP2537936A1 (fr) 2012-12-26
DK2723873T4 (da) 2020-04-20
TN2013000498A1 (fr) 2015-03-30
UA114603C2 (uk) 2017-07-10
US9932603B2 (en) 2018-04-03
PT2723873T (pt) 2017-10-04
HUE035070T2 (en) 2018-05-02
EP2723873A1 (fr) 2014-04-30
EP2723873B1 (fr) 2017-08-09
CA2839371A1 (fr) 2012-12-27
US10662438B2 (en) 2020-05-26
ES2647077T5 (es) 2020-10-05
CN103635581B (zh) 2016-08-10
DK2723873T3 (da) 2017-11-20
WO2012175420A1 (fr) 2012-12-27
US20140317779A1 (en) 2014-10-23
EA029359B1 (ru) 2018-03-30
CL2013003466A1 (es) 2014-08-08
ES2647077T3 (es) 2017-12-19
LT2723873T (lt) 2018-02-12
PL2723873T3 (pl) 2018-01-31

Similar Documents

Publication Publication Date Title
IL284578A (en) Double-stranded RNA suppressors of the hepatitis B virus, preparations containing them and their uses
JOP20200092A1 (ar) تركيبات iRNA لفيروس الكبد B (HBV) وطرق لاستخدامها
WO2015042308A3 (fr) Inhibiteurs du vih à base d'arn
HUE057725T2 (hu) Módosított nukleozidok, nukleotidok és nukleinsavak és ezek felhasználása
EP4659765A3 (fr) Délétion d'exon du gène codant la dystrophine au moyen de nucléases génétiquement modifiées
MX356625B (es) Oligonucleotidos para elaborar un cambio en la secuencia de una molécula de ácido ribonucleico objetivo presente en una célula viva.
EP3334843A4 (fr) Séquençage monomoléculaire d'adn plasmatique
MX385048B (es) Composiciones y metodos para inhibir la expresion del gen alas1.
MX2015007925A (es) Nucleosidos sustituidos, nucleotidos y analogos de los mismos.
HK1203513A1 (en) Methods of preparing substituted nucleotide analogs
MX2019006413A (es) Composiciones de arni de serpinc1 y metodos de uso de las mismas.
WO2013016352A8 (fr) Produits viraux recombinants et procédés pour inhibition de l'expression de dux4
BR112013030824A8 (pt) Bactéria gram-positiva, ácido necleico recombinante, composição farmacêutica e vetor
IN2014CN03921A (fr)
IN2014KN02769A (fr)
EP3380611A4 (fr) Production de virus dans une culture cellulaire
TN2014000327A1 (en) Oligonucleotides for modulating gene expression and uses thereof
NZ703095A (en) Oligonucleotide chelate complex-polypeptide compositions and methods
EP2931913A4 (fr) Assemblage à médiation par peg de molécules d'acide nucléique
MA35283B1 (fr) Produits de recombinaison destinés à inactiver le gène p0 et leur utilisation
JP2014532403A5 (fr)
WO2013148212A8 (fr) Acides nucléiques destinés à une amplification d'acide nucléique
HK1223129A1 (zh) 基因表现生物标记及其於潜在需要组蛋白去乙醯酶抑制剂治疗的患者的诊断和预後应用中的使用
EP3631006A4 (fr) Stabilisation d'arn au moyen d'adn
WO2013188789A3 (fr) Procédé à l'échelle du génome d'évaluation d'interactions entre des entités chimiques et leurs molécules cibles